Skip to main content

ER 4 2.25 (Pramipexole Dihydrochloride Extended-Release 2.25 mg)

Pill with imprint ER 4 2.25 is White, Elliptical/Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 2.25 mg. It is supplied by Macleods Pharmaceuticals Limited.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ER 4 2.25

Pramipexole Dihydrochloride Extended-Release

ER 4 2.25
2.25 mg
12.00 mm
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, mannitol, corn starch, carbomer homopolymer type C, magnesium stearate, silicon dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "ER 4 2.25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.